Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Ambroxol Potential treatment - pre-clinical evidence Natural product Other treatment Apr/22/2021 2 0
Cynaroside Potential treatment - theoretical effect Natural product Antiviral Feb/16/2021 3 0
Neohesperidin Potential treatment - theoretical effect Natural product Antiviral Nov/30/2020 2 0
Hydrocortisone Potential treatment - clinical evidence Used to treat other disease Other treatment Sep/02/2020 2 1
Myricitrin Potential treatment - theoretical effect Natural product Antiviral Aug/03/2020 1 0
Icariin Potential treatment - theoretical effect Natural product Antiviral Aug/03/2020 1 0
Quercitrin Potential treatment - theoretical effect Natural product Antiviral Aug/03/2020 1 0
Adenylate-3'-phosphate-[[2'-deoxy-uridine-5'-phosphate]-3'-phosphate] Potential treatment - theoretical effect Experimental Antiviral Aug/03/2020 1 0
AMP-PCP Potential treatment - theoretical effect Experimental Antiviral Aug/03/2020 1 0
Carba-nicotinamide-adenine-dinucleotide Potential treatment - theoretical effect Experimental Antiviral Aug/03/2020 1 0
Excel (.xslx) CSV (.csv)